Stay updated on Efficacy Safety in Primary IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-07T06:46:05.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2, replacing the previous v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T17:39:46.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The change is limited to a revision number update from v3.4.0 to v3.4.1; no study content or functionality appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:32:15.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-05T12:28:28.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page adds a visible glossary and updates QC-related labels (e.g., Last Update Submitted that Met QC Criteria) with Revision: v3.4.0, while older QC wording and the No FEAR Act data phrasing were removed.
    Difference
    0.2%
    Check dated 2026-01-29T06:22:27.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed on the page, replacing the previous v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-15T03:06:57.000Z thumbnail image

Stay in the know with updates to Efficacy Safety in Primary IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.